Cambridge, UK-based Crescendo Biologics will expand its discovery and development collaboration with Japanese pharma company Takeda, which is focused on building Humabody-based therapeutics against undisclosed targets. The expanded collaboration comes following Crescendo’s achievement of its sixth technical milestone within the original collaboration agreement. Source: Pharmatimes 10/12/2020